NYSEReal EstateReit - Healthcare FacilitiesSnapshot 2026-08-31
Reading DOC? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →Intact: The reason to own it still holds.
Healthpeak Properties has stable earnings with EPS guidance raised to $0.48 for 2026. The company reaffirms its 2026 FFO guidance at $1.68 to $1.72 per share. Revenue growth is modest but steady at about 1.7% expected for 2026. The balance sheet is strong, supporting growth and dividend payments near 6%.
Revenue growth is very low at about 1.7%, limiting upside. The stock trades at a high PE of 84.4, which is expensive versus peers. EPS estimates have been lowered recently, signaling risk to earnings. Any sustained decline in NOI or FFO would pressure dividends and valuation.
The price is about 1% above our fair value near $21. Analysts expect roughly 1.7% revenue growth in 2026. Our fair value aligns with the Street median, reflecting modest growth and stable income. We see limited upside beyond current expectations.
Breaks if: Significant deterioration in credit ratings or liquidity
Breaks if: EPS falls below $0.46 in FY26
Breaks if: FFO per share falls below $1.68 in FY26
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This is a long-term thesis on a stable business with a focus on growth and expansion. The current state reflects a mix of strong recent financial performance and ongoing management priorities, but with some valuation concerns.
The market currently prices DOC at an expensive valuation compared to its peers. There is an expectations gap, indicating that the market may not fully justify the current price given the mixed signals on growth and performance.
Fundamentals are likely to show continued strength in certain areas, such as the growth of the Janus Living platform. However, same-store cash NOI growth remains mixed, and there is a moderate risk of missing earnings expectations.
The thesis hinges on management's ability to execute on capital recycling and growth strategies. Additionally, external factors like Federal Reserve interest rate decisions and performance from sector peers will be crucial in shaping future outcomes.
The most important moves since the prior daily snapshot.
Our read on the company is unchanged since the prior snapshot.
as of 2026-08-31
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Breaks if: Revenue growth falls below 1.7% in FY26
Overall, DOC's performance is stable with strong recent results, but its expensive valuation and mixed growth signals warrant careful observation. Not investment advice.
